2010 American Heart Association
2010 American Heart Association
2010 American Heart Association
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
S756 Circulation November 2, <strong>2010</strong><br />
dial ischemia should be treated with �-blockers and consideration<br />
be given to expeditious cardiac catheterization with<br />
revascularization. Magnesium is unlikely to be effective in<br />
preventing polymorphic VT in patients with a normal QT<br />
interval (Class IIb, LOE C), 107 but amiodarone may be effective<br />
(Class IIb, LOE C). 440<br />
Other causes of polymorphic VT apart from ischemia and<br />
long QT syndrome are catecholaminergic VT (which may be<br />
responsive to �-blockers) and Brugada syndrome (which may<br />
be responsive to isoproterenol).<br />
Guidelines Part 8: ACLS Writing Group Disclosures<br />
Writing<br />
Group<br />
Member Employment Research Grant<br />
Robert W.<br />
Neumar<br />
Charles W.<br />
Otto<br />
Mark S.<br />
Link<br />
Steven L.<br />
Kronick<br />
Michael<br />
Shuster<br />
Clifton W.<br />
Callaway<br />
Peter J.<br />
Kudenchuk<br />
Joseph P.<br />
Ornato<br />
University of<br />
Pennsylvania-Associate<br />
Professor of<br />
Emergency Medicine<br />
University of Arizona–<br />
Professor<br />
Tufts Medical Center–<br />
Physician<br />
University of<br />
Michigan–Assistant<br />
Professor<br />
Self-employed–<br />
emergency physician<br />
University of Pittsburgh<br />
School of<br />
Medicine–Associate<br />
Professor; UPMC<br />
Health<br />
System—Physician<br />
*<strong>American</strong> <strong>Heart</strong><br />
<strong>Association</strong>-Work Sheet<br />
Editor for <strong>2010</strong><br />
Guidelines. My effort<br />
on this project is paid<br />
to University of<br />
Pittsburgh as a<br />
�contracted services<br />
agreement,� and not<br />
paid directly to me<br />
University of<br />
Washington–<br />
Professor of Medicine<br />
Richmond Ambulance<br />
Authority–Medical<br />
Director; Virginia<br />
Commonwealth<br />
University-Prof &<br />
Chmn, Emergency<br />
Medicine<br />
Disclosures<br />
Other Research<br />
Support<br />
Summary<br />
The goal of therapy for bradycardia or tachycardia is to<br />
rapidly identify and treat patients who are hemodynamically<br />
unstable or symptomatic due to the arrhythmia. Drugs or,<br />
when appropriate, pacing may be used to control unstable or<br />
symptomatic bradycardia. Cardioversion or drugs or both<br />
may be used to control unstable or symptomatic tachycardia.<br />
ACLS providers should closely monitor stable patients pending<br />
expert consultation and should be prepared to aggressively<br />
treat those with evidence of decompensation.<br />
Speakers’ Bureau/<br />
Honoraria<br />
Ownership<br />
Interest<br />
Consultant/<br />
Advisory Board Other<br />
None None None None None None<br />
None None None None None None<br />
None None None None None None<br />
None None None None None None<br />
None None None None None None<br />
†Grants to<br />
University of<br />
Pittsburgh:<br />
NHLBI-<br />
Resuscitation<br />
Outcomes<br />
Consortium<br />
HRSA-Development<br />
and Dissemination<br />
of Program Tools<br />
for Uncontrolled<br />
Donation After<br />
Cardiac Death<br />
(UDCD)<br />
†Resuscitation<br />
Outcomes<br />
Consortium<br />
(NIH/NHLBI)<br />
†Consultant and<br />
Cardiac Co-Chairman,<br />
NIH Resuscitation<br />
Outcomes<br />
Consortium Principal<br />
Investigator, VCU site<br />
for NIH Neurological<br />
Emergency<br />
Treatment Trials<br />
Network<br />
*Loan of an<br />
Arctic Sun<br />
cooling device<br />
(without<br />
disposables) to<br />
human<br />
physiology<br />
laboratory for<br />
experiments on<br />
hypothermia by<br />
Medivance, Inc.<br />
None Network for Continuing<br />
Medical Education,<br />
Academy for<br />
Healthcare Education,<br />
Sanofi-Aventis, with<br />
honoraria<br />
None *Hospital grand rounds<br />
presentations funded<br />
by ZOLL Circulation<br />
*Occasional hospital<br />
grand rounds<br />
supported by<br />
unrestricted<br />
educational grants<br />
from Squibb/Sanofi,<br />
ZOLL<br />
None †Co-inventor on<br />
patent about<br />
ventricular<br />
fibrillation<br />
waveform<br />
analysis,<br />
licensed by<br />
University of<br />
Pittsburgh to<br />
Medtronic ERS,<br />
Inc.<br />
Sanofi-Aventis,<br />
Novartis<br />
None None<br />
None None<br />
None *ZOLL Circulation<br />
Science Advisory<br />
Board (UNPAID,<br />
only receive<br />
travel<br />
reimbursement)<br />
Downloaded from<br />
circ.ahajournals.org at NATIONAL TAIWAN UNIV on October 18, <strong>2010</strong><br />
None<br />
(Continued)
Change language